Anxiety and depression in perioperative patients with pancreatic cancer and the intervention mode of essential oil aromatherapy

Effects of aromatherapy with essential oils on anxiety and depression in perioperative patients with pancreatic cancer

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400089324

Enrollment

Unknown

Registered

2024-09-05

Start date

2024-01-11

Completion date

Unknown

Last updated

2024-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic carcinoma

Interventions

Experimental group:Aromatherapy with essential oil intervention in perioperative pancreatic cancer patients

Control group:Quality nursing treatment of perioperative patients with pancreatic cancer

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Meet the relevant diagnostic criteria in the Chinese Anti-Cancer Association Guidelines for the Integrated Diagnosis and Treatment of Pancreatic Cancer (Abbreviated version 2023);(2)Age =18 years old, contraception required, non-lactation period;(3)consistent with surgical indications; Surgical procedures included: Whipple, enlarged pancreaticoduodenectomy, corpus and caudectomy, total pancreatectomy, subtotal pancreatectomy, pyloric-preserving pancreaticoduodenectomy; (4)Patients undergoing elective surgery without preoperative radiotherapy or chemotherapy;(5)can communicate normally; (6)Preoperative SAS score =50 or (and)SDS score=53; (7)Informed consent of the subject himself or his guardian;

Exclusion criteria

Exclusion criteria: (1)Have a history of mental illness or cognitive impairment;(2)Patients with severe liver and kidney diseases, severe cardiopulmonary dysfunction, tumor recurrence or metastasis;(3) Those who have allergy or intolerance to aromatic reagents, resulting in the inability to perform the test midway, olfactory disorders, acute respiratory diseases or serious complications (unstable vital signs, blood clotting disorders, irreversible metabolic diseases, etc.); (4)Poor compliance with the intervention protocol of this study or accepting similar researchers at the same time during the study; (5)Termination of participants due to disease treatment and changes in condition;(6)Those who quit on their own for personal reasons; (7)Subjects deemed unsuitable for participation in this study by the investigator.

Design outcomes

Primary

Measure	Time frame
Self-rating Anxiety Scale (SAS);Self-rating Depression Scale (SDS);	—

Countries

CHINA

Contacts

Public ContactLiu Xiaoyi

Peking University First Hospital

13691237353@163.com+86 136 9123 7353

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026